Zions Bancorporation, N.A. Novavax Inc Transaction History

Zions Bancorporation, N.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$36.28 - $75.29 $1,197 - $2,484	-33 Reduced 55.93%	26 $1,000
Q1 2022 May 13, 2022	BUY	$69.73 - $142.9 $3,486 - $7,145	50 Added 555.56%	59 $4,000
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $2,556 - $4,141	-19 Reduced 67.86%	9 $1,000
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $3,378 - $5,141	19 Added 211.11%	28 $6,000
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $1,089 - $2,319	9 New	9 $2,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $629M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.